The Angioedema Treatment Market Is Witnessing Impact From Growth Of The Non-Surgical Aesthetic Sector Driving Factors For The

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Angioedema Treatment Market Grow Between 2026 And 2030?

The angioedema treatment market has observed substantial growth in recent years. Its value is expected to rise from $3.13 billion in 2025 to $3.59 billion in 2026, representing a compound annual growth rate (CAGR) of 14.8%. This historical growth can be linked to factors like emergency allergy management, hospital-based care, the application of corticosteroids, the widespread availability of antihistamines, and the restricted number of targeted medications.

The angioedema treatment market is projected to experience substantial expansion over the upcoming years. This market is set to reach a value of $6.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. Factors contributing to this growth during the forecast period include advancements in biologic drug development, the increase in genetic testing, the proliferation of specialty allergy clinics, enhanced patient education, and a greater emphasis on preventive care. Key trends anticipated for the forecast period encompass a rising adoption of targeted bradykinin therapies, the expansion of hereditary angioedema treatment options, broadened emergency treatment protocols, heightened diagnostic awareness, and a strategic focus on preventive therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

What Key Drivers Are Fueling The Growth Of The Angioedema Treatment Market?

The angioedema treatment market is projected to experience growth due to an increasing occurrence of rare diseases. Rare diseases are characterized as medical conditions affecting a small segment of the population, often accompanied by limited therapeutic options and significant health implications. The prevalence of rare diseases is on the rise, primarily attributed to advancements in genetic testing and diagnostic technologies. These developments enable healthcare professionals to detect and accurately diagnose conditions that were previously overlooked, leading to a higher reported incidence. Angioedema treatment proves beneficial for rare diseases, including hereditary angioedema, by providing targeted therapies that aid in preventing and managing severe swelling episodes, thus improving patient outcomes. For instance, in November 2024, the Food and Drug Administration, a US-based federal agency, indicated that more than 7,000 rare diseases impacted over 30 million individuals in the United States. Therefore, the increasing incidence of rare diseases is a key factor driving the expansion of the angioedema treatment market.

How Is The Angioedema Treatment Market Organized By Segment Classification?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

Subsegments:

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

What Market Trends Are Affecting The Angioedema Treatment Market?

Companies operating in the angioedema treatment market are concentrating on creating innovative solutions, including subcutaneous injections, to provide more convenient and swift relief for patients suffering from acute hereditary angioedema (HAE) attacks. Subcutaneous injections represent a method of delivering medication into the fatty tissue directly beneath the skin, allowing for slow and steady absorption into the bloodstream. As an example of this innovation, CSL Limited, an Australia-based biotechnology company, introduced ANDEMBRY (garadacimab) in April 2025. This novel, fully human monoclonal antibody treatment is intended for the prevention of acute attacks in individuals with hereditary angioedema (HAE). ANDEMBRY stands out as the first pre-filled pen designed for once-monthly subcutaneous administration, offering a practical long-term prophylactic choice. The drug functions by inhibiting activated Factor XII (Factor XIIa), a crucial initiator in the cascade that leads to angioedema. Its introduction marks a significant step forward in HAE management, delivering effective and patient-focused disease control.

Who Are The Industry Participants Involved In The Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Get The Full Angioedema Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

Which Geographic Region Dominates The Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2025. The regions covered in the angioedema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Angioedema Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

Browse Through More Reports Similar to the Global Angioedema Treatment Market 2026, By The Business Research Company

Hereditary Angioedema Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report

Retinal Vein Occlusion Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-treatment-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795